Predictive Oncology Inc [NASDAQ: POAI] price plunged by -2.17 percent to reach at -$0.02.
A sum of 107744 shares traded at recent session while its average daily volume was at 2.67M shares. Predictive Oncology Inc shares reached a high of $0.9544 and dropped to a low of $0.92 until finishing in the latest session at $0.90.
The one-year POAI stock forecast points to a potential upside of 70.0. The average equity rating for POAI stock is currently 3.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Predictive Oncology Inc [POAI]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for POAI shares is $3.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on POAI stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Predictive Oncology Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 19, 2024.
The Average True Range (ATR) for Predictive Oncology Inc is set at 0.08, with the Price to Sales ratio for POAI stock in the period of the last 12 months amounting to 5.96.
POAI Stock Performance Analysis:
Predictive Oncology Inc [POAI] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.95. With this latest performance, POAI shares dropped by -10.00% in over the last four-week period, additionally plugging by 15.40% over the last 6 months – not to mention a drop of -26.23% in the past year of trading.
Insight into Predictive Oncology Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Predictive Oncology Inc [POAI] shares currently have an operating margin of -736.38% and a Gross Margin at 21.92%. Predictive Oncology Inc’s Net Margin is presently recorded at -821.57%.
Return on Equity for this stock declined to -119.63%, with Return on Assets sitting at -119.63%.
Predictive Oncology Inc [POAI] Institutonal Ownership Details
There are presently around $2.07%, or 2.10%% of POAI stock, in the hands of institutional investors. The top three institutional holders of POAI stocks are: VANGUARD GROUP INC with ownership of 71307.0 shares, which is approximately 1.5286%. GEODE CAPITAL MANAGEMENT, LLC, holding 40932.0 shares of the stock with an approximate value of $$42578.0 in POAI stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$36987.0 in POAI stock with ownership which is approximately 0.7624%.
